| Specialty Retail Industry | Consumer Discretionary Sector | René C. Goehrum CEO | TSX-V Exchange | CA0906901081 ISIN |
| CA Country | 60 Employees | 29 May 2026 Last Dividend | - Last Split | - IPO Date |
BioSyent Inc. is a healthcare company that operates both in Canada and internationally with a focus on the acquisition, licensing, development, and commercialization of pharmaceutical and other healthcare products. Originally known as Hedley Technologies Inc., the company underwent a name change to BioSyent Inc. in June 2006. Since its inception, BioSyent Inc. has been dedicated to addressing a variety of health conditions through its diversified product portfolio. The company’s strategic approach includes selling its products through wholesalers and retail pharmacy chains, ensuring wide accessibility and distribution. Headquartered in Mississauga, Canada, BioSyent Inc. has established itself as a key player in the healthcare sector by focusing on innovative solutions for iron deficiency anemia, polycystic ovarian syndrome symptoms, vaginal health, pain management, and more.